Misonix Inc. (MSON) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Misonix Inc. (MSON)

MSON 26.54

0.0%

Nov 22 3:00 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Savant	10/19/2018 4:37:48 PM
	of 947

Misonix to Report Fiscal 2019 First Quarter Financial Results and Host Conference Call and Webcast on November 8 FARMINGDALE, N.Y., Oct. 19, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) ("Misonix" or the "Company"), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, announced today that it will report its fiscal 2019 first quarter financial results after the market closes on Thursday, November 8, 2018. The Company will host a conference call and webcast at 4:30 p.m. ET that day to review the results. Both the call and webcast are open to the general public. To access the conference call, interested parties may dial 800/458-4148 (domestic) or 323/794-2598 (international) conference ID 9334394. Participants may also listen to a live webcast of the call through the "Events and Presentations" section under "Investor Relations" on Misonix's website at www.misonix.com. A webcast replay will be available for 30 days following the live event at www.misonix.com. Please call five minutes in advance to ensure that you are connected. Questions and answers will be taken only from participants on the conference call. For the webcast, please allow 15 minutes to register, download and install any necessary software.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next